You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Medical Management of Ectopic Pregnancy

LIPSCOMB, GARY H. MD

Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0b013e3182510a48
Ectopic Pregnancy
Abstract

The use of medical management of ectopic pregnancy has become an accepted alternative to surgical therapy. Methotrexate, a folic acid antagonist, is the most widely studied agent. The most commonly used protocol consists of methotrexate 50 mg/m2 of actual body weight. Assessment of human chorionic gonadotropin (hCG) levels is repeated on days 4 and 7. Repeat methotrexate dosing is performed for hCG drops <15%. Contraindications include hemodynamically unstable patients or those with elevated liver enzymes, low white blood count, or abnormal renal function. hCG levels are most predictive of success. A success rate of above 90% is achievable.

Author Information

Departments of Family Medicine; Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, Tennessee

The author declares that he has nothing to disclose.

Correspondence: Gary H. Lipscomb, MD, Department Family Medicine, 1301 Primacy Parkway, Memphis, TN 38119. E-mail: glipscomb@uthsc.edu

© 2012 Lippincott Williams & Wilkins, Inc.